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Childhood pneumonia is the leading cause of death of children under the age
of 5 years globally. Diagnostic information on the presence of infection, sever-
ity and aetiology (bacterial versus viral) is crucial for appropriate treatment.
However, the derivation of such information requires advanced equipment
(such as X-rays) and clinical expertise to correctly assess observational clinical
signs (such as chest indrawing); both of these are often unavailable in resource-
constrained settings. In this study, these challenges were addressed through
the development of a suite of data mining tools, facilitating automated diagno-
sis through quantifiable features. Findings were validated on a large dataset
comprising 780 children diagnosed with pneumonia and 801 age-matched
healthy controls. Pneumonia was identified via four quantifiable vital signs
(98.2% sensitivity and 97.6% specificity). Moreover, it was shown that severity
can be determined through a combination of three vital signs and two lung
sounds (72.4% sensitivity and 82.2% specificity); addition of a conventional
biomarker (C-reactive protein) further improved severity predictions (89.1%
sensitivity and 81.3% specificity). Finally, we demonstrated that aetiology
can be determined using three vital signs and a newly proposed biomarker
(lipocalin-2) (81.8% sensitivity and 90.6% specificity). These results suggest
that a suite of carefully designed machine learning tools can be used to support
multi-faceted diagnosis of childhood pneumonia in resource-constrained set-
tings, compensating for the shortage of expensive equipment and highly
trained clinicians.1. Introduction
Pneumonia is the number one killer of children under the age of 5 years (more
than 1.1 million deaths annually), causing more deaths than malaria, tuberculosis
and HIV/AIDS combined [1–3]. More than 95% of the childhood pneumonia
cases and 99% of subsequent deaths occur in developing countries [2]. Appropri-
ate diagnostic assessment of childhood pneumonia typically relies on the use of
advanced tools (such as X-rays and blood culture) as well as interpretation of
observational diagnostic signs (chest indrawing and nasal flaring) by highly
trained clinicians. Moreover, individual measurements are often insufficient
and the clinical expert has to assess a combination of vital signs and other clinical
characteristics for accurate diagnosis [4,5]. However, access to high-quality health-
care may often be limited in many low and middle income countries (LMICs) due
to a shortage of appropriate medical equipment and clinical expertise.
Timely and accurate diagnosis that facilitates appropriate treatment has been
reported to have the potential to reduce mortality by as much as 42% [3]. Most
childhood pneumonia deaths are reported to occur in a relatively early stage of
disease progression and complications can develop quickly. In resource-
constrained settings, hospital facilities are often remote and community health

































































Figure 1. (a) Summary of sensitivity and specificity of individual clinical characteristics, derived from applying a threshold (as per standard clinical guidelines),
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that severity can be determined as early and as accurately as
possible in a point-of-care setting.
The World Health Organization (WHO) has developed a
set of guidelines for diagnosis of childhood pneumonia in
resource-constrained settings, directing health workers through
identification of pneumonia and antibiotic prescription or
hospitalization—the guidelines for integrated management
of childhood illness (IMCI) [6]. However, a series of reports
investigating the integration of these guidelines into clinical
practice worldwide have reported reasonably high sensitivity
of derived diagnosis (69–94%), overshadowed by poor speci-
ficity (16–67%) [7–9]. Consequently, unnecessary antibiotic
prescription has risen, causing depletion of drug stocks and
microbial resistance. Thus, it is essential that more specific
(but equally sensitive) diagnostic tools are developed, and
that objective measurements are used to reduce intra- and
inter-user variability in diagnostic performance. Additionally,
novel and affordable tools for determination of aetiology
should be developed—currently, a combination of chest X-ray
and blood culture are required for this.
Machine learning has been shown to be successful as a tool
for strengthening diagnostic accuracy of hospitalized pneumo-
nia patients: in particular, (i) identifying patients suitable
for treatment at home and reducing healthcare costs [10,11]
and (ii) predicting mortality in hospitalized patients [12,13].
These studies use a wide range of machine learning techniques,
applied to datasets derived from electronic health records
(EHR). EHR contain numerous variables acquired by experts
using advanced diagnostic tools; it is unfeasible that suchrich datasets could be regularly obtained in resource-
constrained settings. Moreover, the focus of most of these
studies is pneumonia in adults and yet manifestations of the
disease in children are considerably different.
By contrast, research on the use of parsimonious datasets,
comprising affordable point-of-care measurements for diag-
nostic support of childhood pneumonia is rare. Traditionally,
basic analytical tools for thresholding individual variables
have been used [14–16] but none of these variables have
been found to be both sensitive and specific enough individu-
ally (figure 1). Abeyratne et al. reported the use of cough
recordings, in combination with fever, deriving algorithms
for automated detection of the cough sounds and subsequent
identification of pneumonia. While this approach appears to
deliver promising sensitivity (94%), specificity is lower (75%)
and no information on severity or aetiology is derived.
Additionally, the approach relies on continuous sound record-
ing of the child in a hospital setting; in practice, consultation
times are typically reported to be less than 2 min due to the
large volume of patients in primary care facilities and the lim-
ited tolerance young children have for physical examinations
[17].
Triaging systems based on data mining of a few basic vital
signs have been investigated in the context of influenza and
epidemic outbreaks in highly populous areas, delivering prom-
ising results (sensitivity and specificity of approximately 85%)
[18,19]. We propose a suite of machine learning techniques for
automated threefold diagnosis of childhood pneumonia
(identification, severity and aetiology) based on variables that:
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tings. Such techniques could provide health workers with
essential information and facilitate holistic evidence-based clini-
cal decisions. In this study, each of the three diagnostic aspects
was addressed separately, where (i) a minimal and most infor-
mative set of features was identified and (ii) machine learning
algorithms were used to combine information from individual
features and improve diagnosis in an automated way. The prac-
tical limitations of feature acquisition in a point-of-care setting
were incorporated and the number of measurements needed
during an examination was minimized. The analysis presented
here builds upon a clinical study investigating the discovery of
novel pneumonia-related biomarkers [20].c.Interface
13:201602662. Data
The dataset analysed here was originally collected as part of a
clinical study described by Huang et al. [20]. The 1581 partici-
pants were Gambian children aged 2–59 months. Various
features were collected for each case. The full dataset consisted
of 57 features (clinical characteristics), including measurable
clinical variables (e.g. white blood cell count, neutrophils,
haemoglobin, etc.), observational clinical characteristics
(e.g. sleepiness, sternal indrawing, cough heard, etc.) and con-
ventional vital signs (e.g. respiratory rate (RR), heart rate
(HR), oxygen saturation (Osat), etc.). Additionally, selected
cases also contained four biomarkers (C-reactive protein
(CRP), lipocalin-2 (Lcn2), haptoglobin (Hap) and CD163
protein). We will demonstrate results on the following subsets:
— Identification dataset (1581 cases, 57 features). Seven hun-
dred and eighty childhood pneumonia and 801 age- and
gender-matched healthy controls were recruited.
— First severity dataset (780 cases, 57 features). From the 780
pneumonia cases, 458 had severe and 322 had non-
severe pneumonia.
— Second severity dataset (180 cases, 61 features). One hundred
and eighty of the pneumonia cases contained biomarker
information—104 severe and 76 non-severe cases.
— Aetiology dataset (84 cases, 61 features). Only 84 cases had
aetiology information, 22 bacterial and 62 viral, as gold
standard diagnosis requires the acquisition of X-rays and
blood culture.
The diagnostic outcome for each case was provided by a clini-
cian, expanding on the WHO [21] and IMCI [6] guidelines. The
criteria for identification of pneumonia and severity determi-
nation are listed in figure 1 and have been discussed in detail
by Scott et al. in their search for a widely accepted clinical
criteria for pneumonia classification [22]. Additionally, X-ray
end consolidation and/or a positive blood culture result were
used to differentiate bacterial from viral pneumonia cases.
Further details on the data acquisition process can be found
in the original clinical study [20].3. Methodology
3.1. Preprocessing
Preprocessing of the original data was performed. The substantial
number of missing values (up to 42% for some of the features) was
addressed through imputation: features and cases containing less
than 85% of the total number of entries were removed; theremaining missing values were imputed using feature median
values (feature mean imputation was also tested but was observed
to deliver equivalent results). Following standard statistical
machine learning methodology, we extended the dimensionality of
the original design matrix. Specifically, we introduced additional
vectors for each feature that mirrored imputations—these vectors
contained ‘ones’ where imputation was done and ‘zeros’ otherwise
[23]. We will refer to these vectors as ‘ghost vectors’ throughout
this study.
Several clinical features were excluded from the dataset as they
are used in the clinical ‘gold standard’ and cannot be captured in a
quantifiable way, e.g. ‘lower chest wall indrawing’. Details can
be found in the feature list in the electronic supplementary
material, §A.
In addition to imputation, all features were scaled to a similar
range. For continuous valued features, this was achieved by sub-
tracting their minimum value and dividing by their range of
values. For discrete features, a vector of ones was added and
the resulting sum was divided by the maximum values for the
feature plus one, avoiding multiple zero entries. Gaussianizing
of data via the Box–Cox transformation was also attempted
but had no considerable effect on performance.
3.2. Feature selection
Feature selection in this study was driven by considerations
related to data limitations and diagnostic application
— Data considerations. The curse of dimensionality has been
shown to affect even powerful classifiers such as random
forests (RFs) and support vector machines (SVMs) [24–26].
An exhaustive search over all possible feature combinations
to determine the optimal feature subset is computationally
intractable, hence we used a number of well-established
feature selection approaches.
— Diagnostic application considerations. Point-of-care diagnostics
would realistically afford a limited number of features. There-
fore, a feature selection approach that took into account cost,
acquisition time and quantifiability of measurements was used.
Seven feature selection techniques were used to investigate
the predictive ability of features towards the outcome: maximum
relevance on the basis of the linear (Pearson) correlation coefficient,
maximum relevance minimum redundancy (mRMR), relief,
Gram–Schmidt orthogonalization (GSO), least angle shrinkage
and selection operator (LASSO), elastic net (EN) and sparse
linear discriminant analysis (sLDA). A brief description of each
technique is given in the electronic supplementary material.
A majority voting approach that consolidates results from all
techniques was developed in order to dilute the bias of individual
techniques and obtain a more objective selection of features. Using
10-fold cross-validation and 50 repetitions, feature selection was
performed on nine tenths of the data via each one of the seven tech-
niques, after all features were scaled to the same range. The
frequency with which each feature occupied each rank was calcu-
lated across folds and results were averaged across the number of
repetitions. Additionally, normalized scores were derived to reflect
the overall frequency of ranks. This approach is summarized in the
pseudo-code figure 2. Next, two inclusion conditions were
applied. First, a feature should appear in the top 10 of at least
three ‘fundamentally different’ techniques; the pairs (correlation
and mRMR) and (LASSO and EN) share conceptually similar
theoretical bases and are not ‘fundamentally different’. Second,
the feature should be measurable in a point-of-care setting in an
affordable way. The scores associated with selected features were
used to derive a feature ranking. The SpaSM toolbox was used
to perform LASSO, EN and sLDA in MATLAB [27]; we used our
own custom-based implementations for the remaining feature
selection algorithms.
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The IMCI guidelines are widely used by CHWs in low-resource
settings to identify children at risk of pneumonia. In this paper,
we compare a number of machine learning techniques with the
potential to improve performance of the IMCI guidelines. Histori-
cally, logistic regression (LR) has been the most popular technique
in classification contexts in the medical domain, including assess-
ment of pneumonia. In this study, LR was used as a benchmark
technique and the applicability of two other classifiers, SVMs
and RFs, was investigated. The application of all three techniques
to various medical diagnostics problems has been well-documented
in the literature [28,29] and a brief overview of the underlying
principles is given in the electronic supplementary material.
3.4. Performance generalization
The generalization of each machine learning algorithm (i.e. its
expected performance on unseen data) was assessed using either
fourfold cross-validation (for the bigger data subsets) or leave-
one-out (for the smaller data subsets). For each training set,
preprocessing as described in §3.1 was performed; these oper-
ations were then applied to the test set, using characteristic
parameters derived from the training set. Additionally, internal
fivefold cross-validation was performed to optimize classifier par-
ameters in each training set, based on area under the curve (AUC).
Using the feature ranking, an increasing number of features
were gradually fed into the classifier, with a separate algorithm
trained for each number. The following performance metrics were
recorded from the test set: sensitivity, specificity, AUC, balanced
accuracy and Matthew’s correlation coefficient (MCC), where the
latter two were defined as: balanced accuracy¼ 0.5 (sensitivity þ
specificity); MCC ¼ (TP  TN 2 FP FN)/p(TP þ FP)(TPþ
FN)(TNþ FP)(TNþ FN), where TP¼ true positive, TN¼ true
negative, FP¼ false positive and FN¼ false negative. MCC and
balanced accuracy were used to account for the disproportionality
of outcomes, particularly evident in the aetiology dataset.In a thorough validation approach, the steps above were
repeated 20 times to offset any bias in the split of the data into
train and test, and assess performance variance (which ideally
will be low in order to have confidence in the reported errors).
Algorithm performance in this paper is reported in terms of
mean values and variance across the repetitions. The performance
of the three classifiers was assessed, identifying both the optimal
number of features as well as the best performing algorithm.
3.5. Visualization for interpretation
Childhood pneumonia presents through a complex inter-action of
symptoms. Therefore, visualization of the identified diagnostic
features was necessary to link this data-driven approach back to
the clinical rationale. A dimensionality reduction technique
called t-stochastic neighbourhood embedding (t-SNE) was applied
[30]. Medical data, such as the pneumonia data used in this study,
occupies nonlinear manifolds; consequently, linear methods such
as principal component analysis (PCA) [31] and multidimensional-
ity scaling (MDS) [32] are insufficient as they mainly preserve
the separation between dissimilar data entries within a low-
dimensional space, at the expense of closure information concerning
similar entries. t-SNE has been previously reported to capture
aspects of both the local as well as the global structure, preserving
the neighbouring probabilities of samples. It calculates Euclidean
distances between data entries and derives similarities (conditional
probabilities) by assuming a Student-t distribution [30]. In this
study, t-SNE was used for projecting the higher dimensional
feature space onto a two-dimensional space.4. Results
Results for each of the three diagnostic challenges are presented
separately in §4. Additionally, the electronic supplementary







































































Figure 3. (a) Receiver operating characteristic (ROC) curve for the three classifier applied to the problem of identifying pneumonia; the location of the test results on
the ROC curve as per the MCC optimization are denoted via an ‘asterisk’. (b) Distribution of malnutrition values (measured via the WHO Z-score) across pneumonia
(square) cases and controls (circle); t-SNE has been applied to all five clinical characteristics in order to reduce dimensionality to two dimensions, leading to the
creation of two mostly independent ‘clusters’. The colour scale represents the corresponding Z-score per entry. The boxes on the right contain the following infor-
mation: (top) correlation coefficient between the malnutrition feature and outcome; (middle) colour bar for the colour scale used in the plot; (bottom) a boxplot of
the malnutrition data, split between the two classes. In the latter, the central/red line represents the median, the edges are the 25th and the 75th percentiles, and
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worse results than those reported here. Nevertheless, these les-
sons can be of value to the research community and others
working on this specific problem.
4.1. Disease identification
Applying the feature selection methodology outlined pre-
viously, the following feature subset was selected: RR, HR,
temperature (T), malnutrition (WHZ) and Osat, listed in des-
cending order of importance. A full list of the selected
features can be found in the electronic supplementary material,
figure S1. RR, HR, T and Osat had 13 missing values each,
WHZ had 22. Values were imputed using the procedure
described in §3.1., leading to the creation of five ghost vectors.
We experimented with different loss function approaches
(balanced accuracy, MCC) for the three classifiers tested
(LR, SVM, RF). The MCC was observed to be most favourable,
optimizing performance in the test set as a result of fine-tuning
of model parameters in the training/validation set. Specifi-
cally, for SVM, a Gaussian radial basis function kernel, with
a kernel width, g, of 0.1 and a cost parameter of 1000 were
found to deliver the best performance; for RF, 750 decision
trees and searching over two variables at each tree node were
the optimal hyperparameters.
The three classification techniques exhibited comparable
performance, with somewhat more favourable sensitivity and
specificity obtained with RF (figure 3a). LR was seen to some-
times outperform SVM but exhibited larger variance. The
addition of the ghost vectors had a very limited effect on classi-
fication performance, with changes in all metrics limited to
+1%. Taking a closer look at the RF algorithm, four features
(RR, HR, Osat and T), with the addition of age, delivered maxi-
mal results: 98.2% (95% CI 97.9–98.8%) sensitivity; 97.6% (95%
CI 97.1–98.0%) specificity; 99.7% (95% CI 99.3–99.8%) AUC;
95.9% (95% CI 95.3–96.5%) MCC. From the cases that were fal-
sely classified as controls, 33% were severe pneumonia.
Moreover, reducing the number of features to three, worsened
performance marginally: 98.2% (95% CI 97.8–98.6%)sensitivity; 97.1% (95% CI 96.8–97.5%) specificity; 99.6%
(95% CI 99.5–99.6%) AUC; 95.2% (95% CI 94.9–96.1%)
MCC. Somewhat surprisingly, the addition of malnutrition did
not improve results. The distribution of malnutrition values
across the two classes (pneumonia and controls) was further
examined on the basis of t-SNE dimensionality reduction
(figure 3b).
4.2. Severity determination
The aim of this part of the analysis was to investigate whether it
is possible to predict severity using quantifiable features rather
than the observational features included in the ‘gold standard’
guidelines such as ‘chest wall indrawing’. Additionally, it was
also investigated whether biomarkers could be fused with vital
signs to improve severity prediction. For the purposes of an
early warning algorithm, severity was divided into ‘non-
severe’ and ‘severe’, with the latter combining both severe
and very severe pneumonia cases.
In the first severity dataset, selected features were: RR,
Osat, crackles, grunting, HR. In the second severity dataset,
selected features were: RR, grunting, crackles, CRP, HR,
Osat, CD163, Hap, Lcn2. A full list of the selected features
is available in the electronic supplementary material, figure
S2. In the first severity dataset, all five features had less
than three missing values each, introducing five ghost vec-
tors. In the second severity dataset, the clinical signs had
no missing values and the missing values among the bio-
markers were less than 8% (after exclusion of 19 cases that
were missing seven out of nine features), introducing four
ghost vectors.
First, the mixture of vital signs and lung sounds, listed for
the first severity dataset, was used to classify severity
(figure 4). The following hyperparameters were found to
lead to best performance: a Gaussian radial basis function
kernel, with a kernel with g of 0.01 and a cost parameter of
10 000 for SVM; 750 decision trees and searching over two
variables at each tree node for RF. MCC proved to be the
most suitable optimization metric. Some differences were
sensitivity














































Figure 4. Classifiers’ performance in determining severity, reported as sensitivity (a) and specificity (b) for an increasing number of features. Along the x-axis, features
are listed in an additive manner, i.e. each x-entry represents classification with that specific feature and all features on the left of it. Additionally, age was added to the
classifier throughout. Values represent the mean as well as the minimum and maximum values attained across the multiple iterations. Note that the scale of the y-axis is












































































Figure 5. (a) Receiver operating characteristic (ROC) curve for the three classifier applied to the problem of determining severity; the location of the test results on
the ROC curve as per the MCC optimization are denoted via an asterisk. (b) Distribution of CRP values across 10 probabilistic groups/bins. Along the x-axis, the range
of RF probabilistic predictions was divided into 10 bins, where bin 1 contains cases assigned probabilities between [0,0.1], i.e. 90 – 100% certainty of non-severe
pneumonia, and bin 10 contains cases assigned probabilities between [0.9,1], i.e. 90 – 100% certainty of severe pneumonia. The number of predicted cases in bins
1 – 10 were: 29, 21, 14, 23, 12, 7, 19, 23, 23, 28. In each bin, the feature distribution of correctly classified cases is visualized via a boxplot. In each box, the central
dot represents the median, the edges are the 25th and the 75th percentiles, and the thin lines extend to the most extreme data points. Misclassified cases in each
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comparably, whereas LR achieved better sensitivity at the
cost of specificity (figures 4 and 5). The addition of the ghost
vectors had very limited effect on classification, with changes
in all metrics limited to +0.8%. With five features (and age):
LR delivered sensitivity of 84.6% (95% CI 83.6–85.2%); speci-
ficity of 68.3% (95% CI 67.5–69.3%); AUC of 83.7% (95% CI
83.2–83.8%); MCC of 53.6% (95% CI 52.1–55.2%); RF delivered
sensitivity of 71.8% (95% CI 70.0%–76.6%); specificity of 81.8%
(95% CI 73.3–83.5%); AUC of 83.5% (95% CI 82.5–83.8%);
MCC of 52.9% (95% CI 49.6–55.2%).
The five clinical features listed above could be extracted
via two measurements, keeping cost down, while also ensur-
ing feasibility. Biomarkers could be used to improve
performance but are associated with additional cost (both for
the development of the assay, if it does not exist, as well as
the cost of individual probes). Consequently, when introducingbiomarkers to the feature set we attempted to keep their
number as low as possible (one or two) and identify optimal
combinations (table 1). CRP and Hap added to the three vital
signs and two lung sounds, were seen to deliver best results:
sensitivity of 91.4% (95% CI 89.4%–92.3%); specificity of
83.2% (95% CI 82.1–84.2%); AUC of 94.2% (95% CI 93.7–
94.3%); MCC of 73.9% (95% CI 72.8–77.0%). However, with
just one biomarker (CRP) and the same list of remaining fea-
tures, performance was not much worse: sensitivity of 88.5%
(95% CI 87.5%–90.4%); specificity of 82.1% (95% CI 80.0–
84.2%); AUC of 92.3% (95% CI 92.0–94.9%); MCC of 71.8%
(95% CI 68.9–72.9%). The reported results were obtained with
RF; with more than five features, LR’s specificity fell below
60% and computational time with SVM was very long (17 h
for the full validation routine, compared with 2 h with RF).
Taking a closer look at the classifier’s predictions, most
cases from both classes were classified with high level of




































































Figure 6. (a) Receiver operating characteristic (ROC) curve for the three classifier applied to the problem of aetiology determination; the location of the test results
on the ROC curve as per the MCC optimization are denoted via an ‘asterisk’. (b) Distribution of Lcn2 values across 10 probabilistic bins, presented as in figure 5. The
number of predicted cases in bins 1 – 10 were: 42, 14, 4, 3, 4, 4, 2, 5, 4, 7. Misclassified cases in each bin are plotted on top of the boxplot with squares denoting
bacterial and circles denoting viral cases.
Table 1. Sensitivity and specificity of severity determination. First, biomarkers are added individually, followed by combinations of pairs of the top three
performing biomarkers. With five features, LR outperformed RF’s sensitivity; with more features, RF delivered both greater sensitivity and specificity.
no. features features list sensitivity specificity
5a RR, HR, Osat, crackles, grunting 0.85 0.68
5b RR, HR, Osat, crackles, grunting 0.72 0.82
6b RR, HR, Osat, crackles, grunting þ CRP 0.89 0.82
6b RR, HR, Osat, crackles, grunting þ Lcn2 0.87 0.8
6b RR, HR, Osat, crackles, grunting þ Hap 0.88 0.79
6b RR, HR, Osat, crackles, grunting þ CD163 0.88 0.77
7b RR, HR, Osat, crackles, grunting þ CRP þ Lcn2 0.91 0.78
7b RR, HR, Osat, crackles, grunting þ CRP þ Hap 0.91 0.83







 on February 17, 2017http://rsif.royalsocietypublishing.org/Downloaded from certainty. To trace the roots of any uncertainty, the probabilistic
outcomes were split into 10 bins and the distribution of indi-
vidual features in each bin was investigated (CRP in figure 5
and RR in the electronic supplementary material, figure S4).
From this, bins 1 and 2, and, 9 and 10 contained only one mis-
classified case and displayed a substantial difference between
their CRP and RR values. Cases with more moderate CRP
and RR values led to more uncertainty and consequently
higher misclassification rates.
Finally, the IMCI severity guidelines were used for com-
parison, delivering 79.3% sensitivity and 67.7% specificity
(first severity dataset).4.3. Aetiology determination
This part of the study explored whether a combination of
vital signs and biomarkers could be used to predict aetiology
(bacterial versus viral), providing a potential alternative in set-
tings where X-rays and blood culture laboratories are unavailable.
The feature selection identified six features: Lcn2, Hap,
RR, CRP, HR, CD163; a full list of selected features isavailable in the electronic supplementary material, figure
S3. Missing values were imputed using the median value of
features, where imputation was under 10% in all concerned
features, leading to the creation of four ghost vectors.
Optimization of hyperparameters was performed via
MCC, selecting a g of 0.01 and a cost parameter of 1000; and
750 decision trees and searching over three variables at each
tree node for RF. Substantial differences were observed in the
performance of the three classifiers (figure 6a)—SVM was
seen to underperform despite efforts to fine-tune the two
relevant hyperparameters. RF was seen to deliver better sensi-
tivity than LR for a comparable specificity. Similarly to the
severity part of the study, biomarkers were added to the feature
set, aiming to minimize the number required to achieve satis-
factory classification results (table 2). The addition of Lcn2 to
RR, HR and Osat was seen to deliver good performance: sensi-
tivity of 81.8% (95% CI 81.8–81.8%); specificity of 90.6% (95%
CI 89.1–92.2%); AUC of 91.6% (95% CI 89.6–92.8%); MCC of
70.5% (95% CI 68.1–73.0%). Adding a second biomarker did
not improve results. The addition of ghost vectors led to
marginal changes in performance (+0.7%).
Table 2. Sensitivity and specificity of RF for prediction of aetiology. The best performing biomarker was identified first; combinations with a second biomarker
were explored with no substantial change in performance.
no. features features list sensitivity specificity
3 RR, HR, Osat 0.50 0.86
4 RR, HR, Osat þ CRP 0.64 0.88
4 RR, HR, Osat þ Lcn2 0.82 0.91
4 RR, HR, Osat þ Hap 0.64 0.86
4 RR, HR, Osat þ CD163 0.46 0.91
5 RR, HR, Osat þ Lcn2 þ CRP 0.82 0.88
5 RR, HR, Osat þ Lcn2 þ Hap 0.82 0.91
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were split into bins and the distribution of individual features
across these bins was studied (figure 6b). Cases with Lcn2
values below 200 ng ml21, were classified as viral with a
high degree of certainty. However, three bacterial cases were
seen to have Lcn2 values in that range and some viral cases
also presented with elevated Lcn2. Additionally, the relation-
ship between severity and aetiology of pneumonia is not
straight-forward. The available dataset contained a mixture
of cases spread across the severity and aetiology categories:
from the bacterial cases, 10 were severe and 12 non-severe;
from the viral cases, 12 were severe and 52 non-severe. Three
of the severe cases (13.6%) were misclassified in terms of
their aetiology. Based on the IMCI guidelines, all 86 cases
should have been administered antibiotics. Hence, according
to the IMCI guidelines, 100% of the viral cases would have
been misclassified according to their aetiology.5. Discussion and conclusion
Childhood pneumonia presents a severe global health chal-
lenge, costing the lives of more than a million young children
annually. Affordable and timely diagnostics that facilitate
appropriate treatment could help save many of these lives.
However, existing diagnostic approaches are often inappropri-
ate for resource-constrained settings and novel techniques are
required to leapfrog the gap in medical expertise and expensive
equipment. Data mining has the potential to offer such a diag-
nostic remedy, if utilised in a clinically driven and user-centric
manner. This study investigated the use of a suite of machine
learning techniques to derive clinical insights regarding a hol-
istic diagnostic assessment, including identification, severity
and aetiology determination. The proposed approach applied
to eight features (four vital signs (RR, HR, Osat, T), two lung
sounds (grunting, crackles) and two biomarkers (CRP, Lcn2))
could: identify pneumonia with 98.2% sensitivity and 97.6%
specificity; determine severity with 89.1% sensitivity and
81.2% specificity; and determine aetiology with 81.8% sensi-
tivity and 90.6% specificity. These findings are very clinically
relevant as they suggest that machine learning could be used
to strengthen the capacity of health system in low-resource set-
tings to deal with childhood pneumonia, despite sparsity of
advanced equipment and highly trained clinicians.
The purpose of the analysis was not to simply automate the
guidelines but rather to offer a more accurate and reproduciblealternative. To achieve this, some of the features highlighted by
the feature selection techniques as predictive (‘cough’, ‘days
unwell’, ‘head nodding’) were excluded because they could not
be measured unambiguously. Both ‘cough’ and ‘days unwell’
rely on a parent’s careful observations. Similarly, features con-
taining a huge degree of variability between providers of
health (e.g. head nodding) were also excluded. However, lung
sounds (‘crackles’, ‘grunting’, ‘bronchial breathing’) were kept
in the feature set as recent technological advancements have indi-
cated that the acquisition of lung sounds could be automated
through appropriate signal processing.
Some of the selected features were grouped together,
e.g. RR, HR and Osat in figure 4, regardless of the ranking
order derived during feature selection. This was done in order
to illustrate that some features could be obtained through the
same measurement/signal, reducing complexity of clinical
examination and cost. For example, the PPG signal obtained
through a pulse oximeter could be used to derive RR, HR
and Osat. Similarly, multiple lung sounds (crackles, grunting,
bronchial breathing) can be obtained through a single
stethoscope measurement.
From the classifiers examined, RF was seen to outperform
other methods (including LR which is conventionally used in
clinical studies), indicating likely nonlinear interaction between
the clinical signs measured. Identification of pneumonia was
achieved with a high degree of confidence using four clinical
features that could be derived from just two measurements—
a PPG measurement (delivering RR, HR and Osat) and a
temperature measurement. However, the dataset analysed in
this study contained some limitations. Specifically, the control
cases were generally quite healthy (apart from some odd cases
of elevated HR and low SpO2). In a realistic clinical setting
children will also present with various other diseases; therefore,
a reliable evidence-based machine learning algorithm should
ideally be trained to differentiate childhood pneumonia from
other conditions that might appear similar (e.g. malaria or
tuberculosis).
The severity analysis elucidated a few key findings. First,
with three vital signs and two lung sounds, it was possible to
determine severity with high specificity (82.2%) but lower
sensitivity (72.4%) using an RF algorithm. However, keeping
the diagnostic application in mind, low sensitivity would
mean severely ill children who should have been referred to
hospital get missed. The use of LR had the opposite effect,
favouring sensitivity at the expense of specificity (figure 4).
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non-severe cases. Future work could consider combining the
two algorithms to defuse some of this uncertainty. Second,
the addition of biomarkers was seen to only improve sensi-
tivity, with very limited changes to specificity (table 1). With
or without biomarker information, fusion of features via
machine learning was seen to outperform the IMCI guidelines
for severity (as demonstrated in §4.2.), where the latter uses
observational and unquantifiable features.
Finally, the study also suggested an alternative source of
aetiology information, which is typically obtained using X-rays
and blood culture, by combining a couple of vital signs with a
recently proposed biomarker (Lcn2). Moreover, only three out
of the 22 severe cases were misclassified (13.6%) in terms of
their aetiology. Misclassifications within the aetiology problem
would be most detrimental in cases of severe bacterial/viral
pneumonia as this could hinder the timely administration of
appropriate treatment. This information could be crucial in set-
tings where access to advanced medical technologies is limited,
provided a point-of-care test for Lcn2 is developed. In order to
reliably validate the ability of this approach to replace the use
of X-rays and blood culture, especially in settings where these
are not available, a bigger dataset would be required.
Multiple risk factors associated with pneumonia have been
identified in the literature, with malnutrition playing a sub-
stantial role in the clinical outcome. Specifically, malnutrition
has been quoted as an underlying factor in 35% of deaths
in children under 5-years old, including those from pneumonia
[2]. Pneumonia in severely malnourished children is often
undetected, in the absence of advanced imaging, leading to
high mortality. In the dataset analysed here, extreme malnu-
trition scores (from figure 3b, scores less than 24 and more
than 1) were seen to be related to the presence of pneumonia,
confirming the status of malnutrition as a high risk factor.
However, moderate malnutrition scores were seen to be
equally distributed across both pneumonia and controls.
Additionally, malnutrition showed limited significance to pre-
diction of severity or aetiology. Nevertheless, it is expected
that malnutrition would be more relevant as a predictor of
survival but the dataset available did not contain information
on such outcomes.
Biomarkers were included in the analysis despite the fact
that affordable point-of-care tools might not be commercially
available for all of them yet. Nevertheless, research in this
area has delivered promising results. For example, Martinez
et al. reported a production price of US$0.01 for a paper-based
analytical device and multiple applications for this type of tech-
nology have been explored [33]. Point-of-care assays for
CRP have been developed by several commercial providers.
Lcn2 cannot be currently measured in a point-of-care setting.However, the results obtained in this study highlighted that
CRP and Lcn2 could facilitate both severity and aetiology deter-
mination, supporting the need for the development of
affordable point-of-care assays for both biomarkers.
This study provides a theoretical foundation upon which
the research team will be looking to expand both in terms of
the analysis of larger and richer datasets as well as the design
of appropriate point-of-care tools to be used for acquisition of
some of the key parameters (e.g. detection algorithms for
lung sounds via a low-cost digital stethoscope). Hence, a
mobile application connected to low-cost diagnostic tools
(a pulse oximeter and digital stethoscope) has been designed,
with the user interface designed for basically trained CHWs.
As a next step, it is crucial to validate findings on a dataset
obtained in a community setting, where initial triaging for
pneumonia would take place. For this purpose, the research
team is designing a study that will collect data via the
described tools in the community (e.g. in an urban slum),
with outcomes validated at a public hospital. Consequently,
this will allow validation of the proposed machine learning
approach, as well as the development of additional algor-
ithms to (i) differentiate pneumonia from other childhood
diseases, (ii) stratify severity based on disease evolution,
and (iii) predict potential complications early.Data accessibility. The data supporting this article have been registered on
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